Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Other Guidelines

Summary of an interactive meeting about treating babies with CF with modulators before birth

  • Read more about Summary of an interactive meeting about treating babies with CF with modulators before birth

Tracking the spread of Mycobacterium abscessus in a CF center: What bacterial genetics and patient data reveal and why it matters

  • Read more about Tracking the spread of Mycobacterium abscessus in a CF center: What bacterial genetics and patient data reveal and why it matters

CFAbd-Score.kid: a new, child-friendly version of the CFAbd-Score for tracking abdominal symptoms in children with cystic fibrosis

  • Read more about CFAbd-Score.kid: a new, child-friendly version of the CFAbd-Score for tracking abdominal symptoms in children with cystic fibrosis

How doctors decide to prescribe CFTR modulator therapies to their patients

  • Read more about How doctors decide to prescribe CFTR modulator therapies to their patients

Can we shorten test time for Lung Clearance Index (a lung function test used in CF)?

  • Read more about Can we shorten test time for Lung Clearance Index (a lung function test used in CF)?

Understanding Symptom Patterns in Adults with Cystic Fibrosis

  • Read more about Understanding Symptom Patterns in Adults with Cystic Fibrosis

The challenges of conducting large clinical studies in cystic fibrosis

  • Read more about The challenges of conducting large clinical studies in cystic fibrosis

What adults with cystic fibrosis in Ireland are eating; How their diets compare to nutrition guidelines and healthy eating scores.

  • Read more about What adults with cystic fibrosis in Ireland are eating; How their diets compare to nutrition guidelines and healthy eating scores.

Can we measure effectiveness of new cystic fibrosis treatments in improving lung health in children with cystic fibrosis aged less than 2 years of age during clinical trials conducted for the approval of new medicines?

  • Read more about Can we measure effectiveness of new cystic fibrosis treatments in improving lung health in children with cystic fibrosis aged less than 2 years of age during clinical trials conducted for the approval of new medicines?

ARE CFTR MODULATORS ESSENTIAL MEDICINES FOR LOW-INCOME COUNTRIES?

  • Read more about ARE CFTR MODULATORS ESSENTIAL MEDICINES FOR LOW-INCOME COUNTRIES?
  • first
  • previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)